Kvantify has embarked on a collaborative effort with Aarhus University and Aalborg University, backed by a DKK 17.4 million grant from Innovation Fund Denmark, to propel quantum computing applications in drug discovery through the ODAQS project1. The initiative, spanning 2026 to 2029, seeks to bridge the gap between quantum software and hardware limitations, allowing researchers to concentrate on scientific inquiry rather than technical hurdles. By converging research in quantum algorithms, software optimization, and automated quantum program generation, the project aims to develop innovative quantum software with a focus on quantum chemistry. This partnership underscores the growing recognition of quantum computing's potential in revolutionizing drug discovery. The ODAQS project's outcome is poised to have significant implications for the field, as it may enable the development of more efficient and effective methods for discovering new drugs, thereby transforming the pharmaceutical industry's approach to research and development.